You Position: Home > Paper

Biochemical recurrence of prostate cancer: the controversial recognition and management

( views:122, downloads:4 )
Author:
No author available
Journal Title:
CHINESE MEDICAL JOURNAL
Issue:
9
DOI:
10.3760/cma.j.issn.0366-6999.2011.09.001
Key Word:
No keyword available

Abstract: @@ Over the past decaade, more and more patients diagnosed as prostate cancer have received radical management attributing to the advent of prostate-specific antigen (PSA) based medical screening.Radical prostatectomy (RP) and radiation therapy (RT) are the most commonly used forms of definitive therapy for clinically localized prostate cancer.However, despite these technique advances, biochemical recurrence (BCR),as determined by subsequent rises in the serum PSA level,is still a challenge that urologists face.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn